Health insights company
Job no longer available
Health insights company
21-100 employees
Job no longer available
21-100 employees
To enable personalised and individualised medicine, by focusing on patients and their individual needs.
Temedica is a digital health company dedicated to enhancing people's health and well-being by providing personalised digital solutions. The company has leveraged artificial intelligence and machine learning to develop a range of products and services that offer personalised health insights. These insights enable users to monitor their symptoms, track their medication use, and improve their overall health outcomes.
With access to a repository of over 40 billion data points, gathered from more than 50,000 diagnoses, Temedica is able to derive valuable health-related insights. These can relate to disease progression, treatment effectiveness, patient journeys and medical adherence. By using data from diverse sources, it can provide actionable feedback to healthcare systems and their patients, which ultimately drives positive change.
With an impressive list of investors, Temedica is poised for rapid expansion as it accelerates the growth of its ecosystem. It is also investing in further development of cutting-edge solutions that improve health outcomes for individuals. All in all, its future looks bright as the company works to revolutionise the digital health landscape and advance its mission of promoting better health and well-being for all.

Freddie
Company Specialist at Welcome to the Jungle
Nov 2022
$29.5m
SERIES B
Jan 2020
$20.1m
SERIES A
Maxvorstadt, Munich, Germany
Marietherese H.
(CCO)Joined the company as Principal of Strategy in 2022, becoming VP of Business Development in 2024 then CCO in 2026. Previously spent 5 years at Simon-Kucher & Partners, ultimately as a Director.
Alexandru Dina-Gargala
(CPO/CTO)Joined the company as VP of Product in 2023, becoming VP of Product and Technology in 2024 then CPO/CTO in 2026. Previously VP of Digital Product at expondo and Head of Product at CrossEngage.
David Newlands
(CFO)Joined the company as VP of Finance and Operations in 2025, becoming CFO in 2026. Previously Director of Finance at Caresyntax and Head of Finance and Investor Relations at Scoutbee.
Moritz Seuster
(CEO)Joined the company as CEO in 2025, while continuing to act as an Advisory in Strategy Finance Operations. Previously COO then CEO at biocrates life sciences where they worked for 6.5 years.
Share this job
